| Particulars |
|
|
|
| Company Name
| Cohance Lifesciences Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
38.26 |
B.V. (₹) |
115.30 |
| Sales(₹ Cr.) |
1,093.51 |
NP (₹ Cr.) |
271.77 |
| NP Var (%) |
-8.00 |
Div% |
0.00 |
| CPS(₹) |
8.60 |
EPS (₹) |
7.10 |
| Traded Value(₹ Lakhs) |
162.14 |
52 Week High |
1,359.00 |
| 52 Week Low |
574.00 |
Price BSE |
582.00 |
| Price NSE |
582.00 |
Market Capital (₹ Cr.) |
22,257.76 |
| P/C Ratio |
67.70 |
P/E Ratio |
81.90 |
| Price Vs.BV |
5.05 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
497.79 |
| NP(₹ Cr.) |
94.29 |
NP Var % |
-32.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
914.50 |
| OPM |
38.18 |
NP |
247.20 |
| NP Var (%) |
15.89 |
EPS |
9.70 |
| PE |
59.98 |
|
|